Jeff L. Vacirca, Director at Odonate Therapeutics, Inc. (ODT), bought 19,231 shares at $26.00 ($500K) on 2019-06-26, disclosed to the SEC on 2019-06-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| Filing → |
| SPPI | BUY | 2022-12-02 | $23K | — | Filing → |
| ODT | BUY | 2019-03-07 | $51K | — | Filing → |
| ODT | BUY | 2017-12-14 | $23K | — | Filing → |